ViroGates (Denmark) Executives
| VIRO Stock | 8.55 0.20 2.29% |
ViroGates employs about 10 people. The company is managed by 5 executives with a total tenure of roughly 24 years, averaging almost 4.0 years of service per executive, having 2.0 employees per reported executive. Analysis of ViroGates' management performance can provide insight into the firm performance.
| Thomas Krarup Insider VP Marketing |
| Mark Silva Insider Chief Officer |
ViroGates |
ViroGates Management Team Effectiveness
The company has return on total asset (ROA) of (0.3851) % which means that it has lost $0.3851 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6204) %, meaning that it generated substantial loss on money invested by shareholders. ViroGates' management efficiency ratios could be used to measure how well ViroGates manages its routine affairs as well as how well it operates its assets and liabilities.ViroGates Workforce Comparison
ViroGates AS is rated first in number of employees category among its peers. The total workforce of Medical Devices industry is at this time estimated at about 355. ViroGates holds roughly 10.0 in number of employees claiming about 2.82% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of (1.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.27) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.27. ViroGates AS Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ViroGates AS Price Series Summation is a cross summation of ViroGates price series and its benchmark/peer.
ViroGates Notable Stakeholders
A ViroGates stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ViroGates often face trade-offs trying to please all of them. ViroGates' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ViroGates' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Krarup | VP Marketing | Profile | |
| Mark Silva | Chief Officer | Profile | |
| Jakob Knudsen | Chief Officer | Profile | |
| Jesper EugenOlsen | CoFounder Officer | Profile | |
| May Dyvelkov | VP Accounting | Profile |
About ViroGates Management Performance
The success or failure of an entity such as ViroGates AS often depends on how effective the management is. ViroGates management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ViroGates management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ViroGates management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ViroGates Workforce Analysis
Traditionally, organizations such as ViroGates use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ViroGates within its industry.ViroGates Manpower Efficiency
Return on ViroGates Manpower
| Revenue Per Employee | 765.6K | |
| Revenue Per Executive | 1.5M | |
| Net Loss Per Employee | 1.8M | |
| Net Loss Per Executive | 3.5M |
Other Information on Investing in ViroGates Stock
ViroGates financial ratios help investors to determine whether ViroGates Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ViroGates with respect to the benefits of owning ViroGates security.